I. Difficulties and Opportunities ——The Development Status of China Biomedical Polymer Materials Industry
Biomedical polymer materials refer to a class of polymer materials used in artificial organs, tissue engineering and regenerative medicine, in vitro and in vivo diagnosis, pharmaceutical preparations and medical devices.
Biomedical materials belong to the category of medical devices, accounting for more than 40% of the market share of medical devices. The acceleration of the population aging and the pursuit of health and longevity by human beings have stimulated the demand for biomedical polymer materials. As a national strategic emerging industry and one of the key development industries in the 14th Five-Year Plan, its market size is increasing by more than 16% yearly. The share of biomedical materials is expected to catch up with the pharmaceutical market and becomes a pillar industry in the next 20 years.
II. Shenzhen Jusing is officially established – developing biomedical materials to create a green and healthy life
Shenzhen Esun Industrial Co., Ltd. has been committed to the industrialization of environmentally friendly materials, and has 20 years of technical accumulation in the biomaterial industry. Based on the development trend of biomedical materials, eSUN together with experts in the field of biomedical materials formally established Shenzhen Jusing Biotechnology Co., Ltd. As a subsidiary of eSUN, Shenzhen Jusing relies on the strengths of eSUN in the research and development as well as application of polylactic acid (PLA), polyglycolide (PGA) and polycaprolactone (PCL) over the years, focusing on biomedical R&D and industrialization of monomers (lactide, glycolide, caprolactone, etc.), polymers (PLA, PCL, PGA, PLGA), 3D printing materials (PEEK, PLA, PCL, etc.), and medical devices.
III. Jusing Strengths——High starting point, full layout, strong technical research and development ability
1. Industry precipitation and patent technology accumulation
eSUN is committed to the industrialization of biomaterials and has 20 years of experience in R&D, production and marketing. Over the years, it has applied for nearly 90 patents in domestic and international, and obtained nearly 50 patents. At the same time, it has established extensive cooperation with international and domestic scientific research institutes, forming a technology development system combining independent R&D with open innovation.
2. The development and accumulation of medical 3D printing
“eSUN” brand 3D printing consumables are world-renowned, such as polylactic acid (PLA), polycaprolactone (PCL), polyether ether ketone (PEEK), TPU, bio-based resin, dental resin, etc. It has rich application scenarios in the fields of vitro rehabilitation, sports medicine, dentistry, and medical beauty. Based on eSUN over ten years of development experience in the 3D printing industry, the full combination of “new materials (biomedical materials) + new technologies (3D printing technology)” will further promote the application of 3D printing technology in the medical field.